Regeneron Pharmaceuticals and Sanofi have announced positive results from their phase 3 trial, titled NOTUS, evaluating Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD). The trial demonstrated that Dupixent significantly reduced COPD exacerbations by 34% (compared to placebo) in patients with moderate-to-severe COPD who also show evidence of type 2 inflammation of
JoinAStudy.ca is proud to offer heartfelt congratulations to Principal Investigator Dr. Anil Gupta for being awarded the prestigious Ontario College of Family Physicians (OCFP) “Award of Excellence“. His contributions to patient care, advocacy, and education have not only made a significant impact on the healthcare landscape in Ontario, but have also set a commendable standard
In a recent podcast, “Dispelling the Myth that RSV is Only a Disease of Childhood,” Dr. Anil Gupta and colleagues tackle a widely held misconception about Respiratory Syncytial Virus (RSV): that it’s solely a disease of childhood. While RSV is well-known for causing respiratory infections in infants and young children, it’s time to shed light on
Two new phase 2 studies suggest that the investigational drug orforglipron, developed by Eli Lilly, shows promise in the treatment of obesity and type 2 diabetes. Currently, GLP-1 agonists (a class of medications utilized in the treatment of type 2 diabetes mellitus and obesity) approved for these conditions are administered via under the skin injection,
Artificial intelligence (AI) has already made significant contributions and changes to many industries, and clinical research is no exception. AI has the potential to revolutionize the way clinical trials are conducted, making them faster, more efficient, and more cost-effective. In this article, we will explore how AI could impact the clinical trial industry in the
Clinical research, like many industries, has become increasingly globalized during the 21st century. Emerging markets in Asia and South America offer access to diverse patient populations, a greater number of subjects for recruitment, more opportunity for global collaboration and increased inclusivity. The globalization of clinical trials reflects a dynamic and interconnected approach to advancing medical
The US Food and Drug Administration (FDA) has granted approval to GlaxoSmithKline (GSK) for Arexvy, the world’s first vaccine designed to protect older adults against respiratory syncytial virus (RSV). RSV is a common respiratory virus that can cause serious illness, particularly in adults over 65 years of age, and in infants and young children. It
Canada has a rich history of involvement in medical research, spanning from early discoveries in the 19th century to groundbreaking advances in the 21st. The country has been, and continues to be home to numerous influential scientists, physicians, and researchers who have made significant impacts on the field of medicine. One of Canada’s most notable
Welcome to our latest blog series, created in recognition of Clinical Trials Day; an annual event observed on May 20th to commemorate the first randomized clinical trial conducted by James Lind in 1747. This day serves as an opportunity to recognize the vital role that clinical trials play in advancing medical research and improving patient
Diabetes research is coming to Stouffville! This fall, Stouffville Medical Centre will host its first clinical trial for type 2 diabetes, for people who have been diagnosed within the past 4 years. JoinAStudy.ca Principal Investigator Dr. Nima Mirtorabi and the medical team in Stouffville are excited to be contributors to the next wave of diabetes
